Global Spine Biologics Market Growth 2021-2026


Jul, 2021 | Report ID: 204093 | 100 | Medical Devices

According to this latest study, the 2021 growth of Spine Biologics will have significant change from previous year. By the most conservative estimates of global Spine Biologics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2229.4 million in 2020. Over the next five years the Spine Biologics market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 2551.8 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Spine Biologics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Bone Graft

Bone Graft Substitute

Platelet Rich Plasma (PRP)

BMAC (Bone Marrow Aspirate Concentrate)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Anterior Cervical Discectomy and Fusion

Posterior Lumbar Interbody Fusion

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Medtronic

Depuy Synthes

Stryker Corporation

Nuvasive

Zimmer Biomet

Orthofix International

Globus Medical

alphatec spine

K2M

Exactech

Wright Medical Technology

X-Spine

Nutech

Arthrex


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Spine Biologics Consumption 2016-2026

2.1.2 Spine Biologics Consumption CAGR by Region

2.2 Spine Biologics Segment by Type

2.2.1 Bone Graft

2.2.2 Bone Graft Substitute

2.2.3 Platelet Rich Plasma (PRP)

2.2.4 BMAC (Bone Marrow Aspirate Concentrate)

2.3 Spine Biologics Sales by Type

2.3.1 Global Spine Biologics Sales Market Share by Type (2016-2021)

2.3.2 Global Spine Biologics Revenue and Market Share by Type (2016-2021)

2.3.3 Global Spine Biologics Sale Price by Type (2016-2021)

2.4 Spine Biologics Segment by Application

2.4.1 Anterior Cervical Discectomy and Fusion

2.4.2 Posterior Lumbar Interbody Fusion

2.4.3 Others

2.5 Spine Biologics Sales by Application

2.5.1 Global Spine Biologics Sale Market Share by Application (2016-2021)

2.5.2 Global Spine Biologics Revenue and Market Share by Application (2016-2021)

2.5.3 Global Spine Biologics Sale Price by Application (2016-2021)

3 Global Spine Biologics by Company

3.1 Global Spine Biologics Sales Market Share by Company

3.1.1 Global Spine Biologics Sales by Company (2019-2021)

3.1.2 Global Spine Biologics Sales Market Share by Company (2019-2021)

3.2 Global Spine Biologics Revenue Market Share by Company

3.2.1 Global Spine Biologics Revenue by Company (2019-2021)

3.2.2 Global Spine Biologics Revenue Market Share by Company (2019-2021)

3.3 Global Spine Biologics Sale Price by Company

3.4 Global Manufacturers Spine Biologics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Spine Biologics Product Location Distribution

3.4.2 Players Spine Biologics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Spine Biologics by Region

4.1 Global Spine Biologics by Region

4.1.1 Global Spine Biologics Sales by Region

4.1.2 Global Spine Biologics Revenue by Region

4.2 Americas Spine Biologics Sales Growth

4.3 APAC Spine Biologics Sales Growth

4.4 Europe Spine Biologics Sales Growth

4.5 Middle East & Africa Spine Biologics Sales Growth

5 Americas

5.1 Americas Spine Biologics Sales by Country

5.1.1 Americas Spine Biologics Sales by Country (2016-2021)

5.1.2 Americas Spine Biologics Revenue by Country (2016-2021)

5.2 Americas Spine Biologics Sales by Type

5.3 Americas Spine Biologics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Spine Biologics Sales by Region

6.1.1 APAC Spine Biologics Sales by Region (2016-2021)

6.1.2 APAC Spine Biologics Revenue by Region (2016-2021)

6.2 APAC Spine Biologics Sales by Type

6.3 APAC Spine Biologics Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Spine Biologics by Country

7.1.1 Europe Spine Biologics Sales by Country (2016-2021)

7.1.2 Europe Spine Biologics Revenue by Country (2016-2021)

7.2 Europe Spine Biologics Sales by Type

7.3 Europe Spine Biologics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Spine Biologics by Country

8.1.1 Middle East & Africa Spine Biologics Sales by Country (2016-2021)

8.1.2 Middle East & Africa Spine Biologics Revenue by Country (2016-2021)

8.2 Middle East & Africa Spine Biologics Sales by Type

8.3 Middle East & Africa Spine Biologics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Spine Biologics Distributors

10.3 Spine Biologics Customer

11 Global Spine Biologics Market Forecast

11.1 Global Spine Biologics Forecast by Region

11.1.1 Global Spine Biologics Forecast by Regions (2021-2026)

11.2.2 Global Spine Biologics Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Spine Biologics Forecast by Type

11.7 Global Spine Biologics Forecast by Application

12 Key Players Analysis

12.1 Medtronic

12.1.1 Medtronic Company Information

12.1.2 Medtronic Spine Biologics Product Offered

12.1.3 Medtronic Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Medtronic Main Business Overview

12.1.5 Medtronic Latest Developments

12.2 Depuy Synthes

12.2.1 Depuy Synthes Company Information

12.2.2 Depuy Synthes Spine Biologics Product Offered

12.2.3 Depuy Synthes Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Depuy Synthes Main Business Overview

12.2.5 Depuy Synthes Latest Developments

12.3 Stryker Corporation

12.3.1 Stryker Corporation Company Information

12.3.2 Stryker Corporation Spine Biologics Product Offered

12.3.3 Stryker Corporation Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Stryker Corporation Main Business Overview

12.3.5 Stryker Corporation Latest Developments

12.4 Nuvasive

12.4.1 Nuvasive Company Information

12.4.2 Nuvasive Spine Biologics Product Offered

12.4.3 Nuvasive Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Nuvasive Main Business Overview

12.4.5 Nuvasive Latest Developments

12.5 Zimmer Biomet

12.5.1 Zimmer Biomet Company Information

12.5.2 Zimmer Biomet Spine Biologics Product Offered

12.5.3 Zimmer Biomet Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Zimmer Biomet Main Business Overview

12.5.5 Zimmer Biomet Latest Developments

12.6 Orthofix International

12.6.1 Orthofix International Company Information

12.6.2 Orthofix International Spine Biologics Product Offered

12.6.3 Orthofix International Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Orthofix International Main Business Overview

12.6.5 Orthofix International Latest Developments

12.7 Globus Medical

12.7.1 Globus Medical Company Information

12.7.2 Globus Medical Spine Biologics Product Offered

12.7.3 Globus Medical Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Globus Medical Main Business Overview

12.7.5 Globus Medical Latest Developments

12.8 alphatec spine

12.8.1 alphatec spine Company Information

12.8.2 alphatec spine Spine Biologics Product Offered

12.8.3 alphatec spine Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 alphatec spine Main Business Overview

12.8.5 alphatec spine Latest Developments

12.9 K2M

12.9.1 K2M Company Information

12.9.2 K2M Spine Biologics Product Offered

12.9.3 K2M Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 K2M Main Business Overview

12.9.5 K2M Latest Developments

12.10 Exactech

12.10.1 Exactech Company Information

12.10.2 Exactech Spine Biologics Product Offered

12.10.3 Exactech Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Exactech Main Business Overview

12.10.5 Exactech Latest Developments

12.11 Wright Medical Technology

12.11.1 Wright Medical Technology Company Information

12.11.2 Wright Medical Technology Spine Biologics Product Offered

12.11.3 Wright Medical Technology Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Wright Medical Technology Main Business Overview

12.11.5 Wright Medical Technology Latest Developments

12.12 X-Spine

12.12.1 X-Spine Company Information

12.12.2 X-Spine Spine Biologics Product Offered

12.12.3 X-Spine Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 X-Spine Main Business Overview

12.12.5 X-Spine Latest Developments

12.13 Nutech

12.13.1 Nutech Company Information

12.13.2 Nutech Spine Biologics Product Offered

12.13.3 Nutech Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Nutech Main Business Overview

12.13.5 Nutech Latest Developments

12.14 Arthrex

12.14.1 Arthrex Company Information

12.14.2 Arthrex Spine Biologics Product Offered

12.14.3 Arthrex Spine Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Arthrex Main Business Overview

12.14.5 Arthrex Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Spine Biologics Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Bone Graft

Table 3. Major Players of Bone Graft Substitute

Table 4. Major Players of Platelet Rich Plasma (PRP)

Table 5. Major Players of BMAC (Bone Marrow Aspirate Concentrate)

Table 6. Global Spine Biologics Sales by Type (2016-2021) & (K Units)

Table 7. Global Spine Biologics Sales Market Share by Type (2016-2021)

Table 8. Global Spine Biologics Revenue by Type (2016-2021) & ($ million)

Table 9. Global Spine Biologics Revenue Market Share by Type (2016-2021)

Table 10. Global Spine Biologics Sale Price by Type (2016-2021)

Table 11. Global Spine Biologics Sales by Application (2016-2021) & (K Units)

Table 12. Global Spine Biologics Sales Market Share by Application (2016-2021)

Table 13. Global Spine Biologics Value by Application (2016-2021)

Table 14. Global Spine Biologics Revenue Market Share by Application (2016-2021)

Table 15. Global Spine Biologics Sale Price by Application (2016-2021)

Table 16. Global Spine Biologics Sales by Company (2019-2021) & (K Units)

Table 17. Global Spine Biologics Sales Market Share by Company (2019-2021)

Table 18. Global Spine Biologics Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Spine Biologics Revenue Market Share by Company (2019-2021)

Table 20. Global Spine Biologics Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Spine Biologics Producing Area Distribution and Sales Area

Table 22. Players Spine Biologics Products Offered

Table 23. Spine Biologics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Spine Biologics Sales by Region (2016-2021) (K Units)

Table 27. Global Spine Biologics Sales Market Share by Region (2016-2021)

Table 28. Global Spine Biologics Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Spine Biologics Revenue Market Share by Region (2016-2021)

Table 30. Americas Spine Biologics Sales by Country (2016-2021) & (K Units)

Table 31. Americas Spine Biologics Sales Market Share by Country (2016-2021)

Table 32. Americas Spine Biologics Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Spine Biologics Revenue Market Share by Country (2016-2021)

Table 34. Americas Spine Biologics Sales by Type (2016-2021) & (K Units)

Table 35. Americas Spine Biologics Sales Market Share by Type (2016-2021)

Table 36. Americas Spine Biologics Sales by Application (2016-2021) & (K Units)

Table 37. Americas Spine Biologics Sales Market Share by Application (2016-2021)

Table 38. APAC Spine Biologics Sales by Region (2016-2021) & (K Units)

Table 39. APAC Spine Biologics Sales Market Share by Region (2016-2021)

Table 40. APAC Spine Biologics Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Spine Biologics Revenue Market Share by Region (2016-2021)

Table 42. APAC Spine Biologics Sales by Type (2016-2021) & (K Units)

Table 43. APAC Spine Biologics Sales Market Share by Type (2016-2021)

Table 44. APAC Spine Biologics Sales by Application (2016-2021) & (K Units)

Table 45. APAC Spine Biologics Sales Market Share by Application (2016-2021)

Table 46. Europe Spine Biologics Sales by Country (2016-2021) & (K Units)

Table 47. Europe Spine Biologics Sales Market Share by Country (2016-2021)

Table 48. Europe Spine Biologics Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Spine Biologics Revenue Market Share by Country (2016-2021)

Table 50. Europe Spine Biologics Sales by Type (2016-2021) & (K Units)

Table 51. Europe Spine Biologics Sales Market Share by Type (2016-2021)

Table 52. Europe Spine Biologics Sales by Application (2016-2021) & (K Units)

Table 53. Europe Spine Biologics Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Spine Biologics Sales by Country (2016-2021) & (K Units)

Table 55. Middle East & Africa Spine Biologics Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Spine Biologics Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Spine Biologics Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Spine Biologics Sales by Type (2016-2021) & (K Units)

Table 59. Middle East & Africa Spine Biologics Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Spine Biologics Sales by Application (2016-2021) & (K Units)

Table 61. Middle East & Africa Spine Biologics Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Spine Biologics

Table 63. Key Application and Potential Industries of Spine Biologics

Table 64. Key Challenges of Spine Biologics

Table 65. Key Trends of Spine Biologics

Table 66. Spine Biologics Distributors List

Table 67. Spine Biologics Customer List

Table 68. Global Spine Biologics Sales Forecast by Region (2021-2026) & (K Units)

Table 69. Global Spine Biologics Consumption Market Forecast by Region

Table 70. Global Spine Biologics Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Spine Biologics Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Spine Biologics Sales Forecast by Country (2021-2026) & (K Units)

Table 73. Americas Spine Biologics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Spine Biologics Sales Forecast by Region (2021-2026) & (K Units)

Table 75. APAC Spine Biologics Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Spine Biologics Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Europe Spine Biologics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Spine Biologics Sales Forecast by Country (2021-2026) & (K Units)

Table 79. Middle East & Africa Spine Biologics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Spine Biologics Sales Forecast by Type (2021-2026) & (K Units)

Table 81. Global Spine Biologics Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Spine Biologics Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Spine Biologics Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Spine Biologics Sales Forecast by Application (2021-2026) & (K Units)

Table 85. Global Spine Biologics Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Spine Biologics Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Spine Biologics Revenue Market Share Forecast by Application (2021-2026)

Table 88. Medtronic Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 89. Medtronic Spine Biologics Product Offered

Table 90. Medtronic Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 91. Medtronic Main Business

Table 92. Medtronic Latest Developments

Table 93. Depuy Synthes Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 94. Depuy Synthes Spine Biologics Product Offered

Table 95. Depuy Synthes Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 96. Depuy Synthes Main Business

Table 97. Depuy Synthes Latest Developments

Table 98. Stryker Corporation Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 99. Stryker Corporation Spine Biologics Product Offered

Table 100. Stryker Corporation Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 101. Stryker Corporation Main Business

Table 102. Stryker Corporation Latest Developments

Table 103. Nuvasive Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 104. Nuvasive Spine Biologics Product Offered

Table 105. Nuvasive Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 106. Nuvasive Main Business

Table 107. Nuvasive Latest Developments

Table 108. Zimmer Biomet Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 109. Zimmer Biomet Spine Biologics Product Offered

Table 110. Zimmer Biomet Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 111. Zimmer Biomet Main Business

Table 112. Zimmer Biomet Latest Developments

Table 113. Orthofix International Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 114. Orthofix International Spine Biologics Product Offered

Table 115. Orthofix International Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 116. Orthofix International Main Business

Table 117. Orthofix International Latest Developments

Table 118. Globus Medical Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 119. Globus Medical Spine Biologics Product Offered

Table 120. Globus Medical Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 121. Globus Medical Main Business

Table 122. Globus Medical Latest Developments

Table 123. alphatec spine Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 124. alphatec spine Spine Biologics Product Offered

Table 125. alphatec spine Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 126. alphatec spine Main Business

Table 127. alphatec spine Latest Developments

Table 128. K2M Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 129. K2M Spine Biologics Product Offered

Table 130. K2M Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 131. K2M Main Business

Table 132. K2M Latest Developments

Table 133. Exactech Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 134. Exactech Spine Biologics Product Offered

Table 135. Exactech Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 136. Exactech Main Business

Table 137. Exactech Latest Developments

Table 138. Wright Medical Technology Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 139. Wright Medical Technology Spine Biologics Product Offered

Table 140. Wright Medical Technology Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 141. Wright Medical Technology Main Business

Table 142. Wright Medical Technology Latest Developments

Table 143. X-Spine Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 144. X-Spine Spine Biologics Product Offered

Table 145. X-Spine Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 146. X-Spine Main Business

Table 147. X-Spine Latest Developments

Table 148. Nutech Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 149. Nutech Spine Biologics Product Offered

Table 150. Nutech Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 151. Nutech Main Business

Table 152. Nutech Latest Developments

Table 153. Arthrex Basic Information, Spine Biologics Manufacturing Base, Sales Area and Its Competitors

Table 154. Arthrex Spine Biologics Product Offered

Table 155. Arthrex Spine Biologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 156. Arthrex Main Business

Table 157. Arthrex Latest Developments

List of Figures

Figure 1. Picture of Spine Biologics

Figure 2. Spine Biologics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Spine Biologics Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Spine Biologics Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Spine Biologics Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Bone Graft

Figure 10. Product Picture of Bone Graft Substitute

Figure 11. Product Picture of Platelet Rich Plasma (PRP)

Figure 12. Product Picture of BMAC (Bone Marrow Aspirate Concentrate)

Figure 13. Global Spine Biologics Sales Market Share by Type in 2020

Figure 14. Global Spine Biologics Revenue Market Share by Type (2016-2021)

Figure 15. Spine Biologics Consumed in Anterior Cervical Discectomy and Fusion

Figure 16. Global Spine Biologics Market: Anterior Cervical Discectomy and Fusion (2016-2021) & (K Units)

Figure 17. Spine Biologics Consumed in Posterior Lumbar Interbody Fusion

Figure 18. Global Spine Biologics Market: Posterior Lumbar Interbody Fusion (2016-2021) & (K Units)

Figure 19. Spine Biologics Consumed in Others

Figure 20. Global Spine Biologics Market: Others (2016-2021) & (K Units)

Figure 21. Global Spine Biologics Sales Market Share by Application (2016-2021)

Figure 22. Global Spine Biologics Revenue Market Share by Application in 2020

Figure 23. Spine Biologics Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Spine Biologics Revenue Market Share by Company in 2020

Figure 25. Global Spine Biologics Sales Market Share by Regions (2016-2021)

Figure 26. Global Spine Biologics Revenue Market Share by Region in 2020

Figure 27. Americas Spine Biologics Sales 2016-2021 (K Units)

Figure 28. Americas Spine Biologics Revenue 2016-2021 ($ Millions)

Figure 29. APAC Spine Biologics Sales 2016-2021 (K Units)

Figure 30. APAC Spine Biologics Revenue 2016-2021 ($ Millions)

Figure 31. Europe Spine Biologics Sales 2016-2021 (K Units)

Figure 32. Europe Spine Biologics Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Spine Biologics Sales 2016-2021 (K Units)

Figure 34. Middle East & Africa Spine Biologics Revenue 2016-2021 ($ Millions)

Figure 35. Americas Spine Biologics Sales Market Share by Country in 2020

Figure 36. Americas Spine Biologics Revenue Market Share by Country in 2020

Figure 37. Americas Spine Biologics Sales Market Share by Type in 2020

Figure 38. Americas Spine Biologics Sales Market Share by Application in 2020

Figure 39. United States Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Spine Biologics Sales Market Share by Region in 2020

Figure 44. APAC Spine Biologics Revenue Market Share by Regions in 2020

Figure 45. APAC Spine Biologics Sales Market Share by Type in 2020

Figure 46. APAC Spine Biologics Sales Market Share by Application in 2020

Figure 47. China Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Spine Biologics Sales Market Share by Country in 2020

Figure 54. Europe Spine Biologics Revenue Market Share by Country in 2020

Figure 55. Europe Spine Biologics Sales Market Share by Type in 2020

Figure 56. Europe Spine Biologics Sales Market Share by Application in 2020

Figure 57. Germany Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Spine Biologics Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Spine Biologics Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Spine Biologics Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Spine Biologics Sales Market Share by Application in 2020

Figure 66. Egypt Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Spine Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

Sample Request is not available